Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Ars Pharmaceutica (Internet)
versión On-line ISSN 2340-9894
Resumen
VEGA-SANCHEZ, Nathalie; MONTERO-JARA, María Fernanda; MARIN-FAJARDO, Rebeca y CHAVARRIA-ROJAS, Marianela. Liposomes in pharmaceutical semisolid dosage forms. Ars Pharm [online]. 2022, vol.63, n.4, pp.372-386. Epub 12-Dic-2022. ISSN 2340-9894. https://dx.doi.org/10.30827/ars.v63i4.26059.
Introduction:
liposomes are spherical phospholipid nanovesicles, an essential characteristic for their permeability. Hence, they are widely used as drug delivery systems for dermal and transdermal administration.
Method:
a bibliographic review of scientific articles and patents published on different information sources was carried out. We reviewed Google Scholar, Google Patents, Pubmed, Elsevier, ScienceDirect, Scielo, and specialized journals, both in English and Spanish. The articles were published between 2012 and 2022, and the most relevant were selected.
Results:
in total, 31 articles and 9 patents were selected, to be evaluated and analyzed. These articles demonstrate the use of liposomes in semisolid dosage forms of various pharmacological categories, such as non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, opioid analgesics, local anesthetics, antibiotics, antifungals, antivirals, antimetabolites, vitamins, phytochemicals, and some cases of skin pathologies treatment.
Conclusions:
nanotechnology and its advances are especially interesting for drug formulation. The use of liposomal systems has become a useful tool, which is beneficial, due to its characteristics, for the formulation of semi-solid dosage forms.
Palabras clave : liposomes; skin; semisolid dosage forms; nanotechnology; dermis; dermal penetration.